Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin.
Hirosuke YamajiTakashi MurakamiKazuyoshi HinaShunichi HigashiyaHiroshi KawamuraMasaaki MurakamiShigeshi KamikawaSatoshi HirohataShozo KusachiPublished in: Journal of cardiovascular electrophysiology (2018)
Edoxaban interrupted on the day of ablation showed a shorter baseline ACT than uninterrupted warfarin. Edoxaban required a higher initial heparin dose to achieve a similar 15-minute ACT to warfarin. These results are useful for determining the initial heparin dose required to achieve variable target ACTs.